Clinical Trial Update: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 2]

View source ↗

Summary

This is a multi-center Phase 2 study evaluating oral Abexinostat as monotherapy for relapsed or refractory follicular lymphoma. The trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Abexinostat (Abexinostat)

Snippet

Sponsor: Xynomic Pharmaceuticals, Inc. | Conditions: Lymphoma, Follicular | Phase 2 | Status: ACTIVE_NOT_RECRUITING